Loading...

Abbott Laboratories (NYSE:ABT)

109.45 USD +3.24 USD ( +3.05% )
Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist

EV/EBIT
Enterprise Value to EBIT

The Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
=
Enterprise Value
/
EBIT
Current EV/EBIT
ABT
21.2
Median EV/EBIT
ABT
34.5
Industry EV/EBIT
Health Care
14.2

EV/EBIT History

Statistics
Enterprise Value to EBIT

1 Year 3 Years 5 Years
Average 26.5 34.2 38.3
Median 26.8 34.5 38.4
Min 21.8 21.8 21.8
Max 31.1 47.5 63.8

History Chart
Enterprise Value to EBIT

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
19.6
2-Years Forward
EV/EBIT
19.4
3-Years Forward
EV/EBIT
17.6

EV/EBIT Across Competitors

ABT Competitors
Abbott Laboratories Competitors

Country Company Market Cap EV/EBIT
US
Abbott Laboratories
NYSE:ABT
193B USD 21.2
IE
Medtronic PLC
NYSE:MDT
120B USD 18.7
US
Stryker Corp
NYSE:SYK
77.3B USD 26.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
75.3B USD 36.9
US
Becton Dickinson and Co
NYSE:BDX
71.5B USD 32.4
US
Edwards Lifesciences Corp
NYSE:EW
60.3B USD 33.6

Relative Valuation Report

View full relative valuation report for Abbott Laboratories, which takes into account all ABT`s valuation multiples.

See Also

Similar Stocks